...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The slow bleed on low volume continues.....

Obviously companies going ahead with ph III trials, RVX, PPHM or any others....obvioulsy there's a level of comfort from earlier trial results, if there wasn't success in phas I/II/IIb then they wouldn't be going forward with ph III.

But that doesn't mean there still isn't a big risk of failure.

Share
New Message
Please login to post a reply